Kyowa Kirin stops development of skin condition treatment
March 3 (Reuters) - Kyowa Kirin 4151.T on Tuesday said it is discontinuing all ongoing trials of its experimental drug to treat skin conditions. (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia